"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to SDGR. [ FAQ on what and how to ask] For non-SDGR questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. Ramy Farid Ph.D.
Headquarter: 1540 Broadway, 24th Floor, New York, NY, United States, 10036
Industry: Health Information Services, Investment Track: AI drug discovery, Employees: 850
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
My Watchlist
